"Well, we're raising money right now to fund the preclinical work to get us to Phase I trials, and then raising to fund the trials themselves. Estimated total cost is about 2.5 million dollars, so I think it's safe for you to say you're raising the money to get us to Phase I trials that can potentially save what sight you have left." -- Cory MacDonald, founder of the Choroideremia Research Foundation.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment